Published in J Natl Cancer Inst on August 01, 1985
Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst (2012) 2.44
Second primary malignancies in thyroid cancer patients. Br J Cancer (2003) 2.10
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers. BMC Cancer (2007) 1.63
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian. MedGenMed (2005) 1.58
The risk of subsequent primary cancers after colorectal cancer in southeast England. Gut (2002) 1.34
Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer (2001) 1.30
Multiple primary cancers in the Vaud Cancer Registry, Switzerland, 1974-89. Br J Cancer (1993) 1.15
Measuring social class differences in cancer patient survival: is it necessary to control for social class differences in general population mortality? A Finnish population-based study. J Epidemiol Community Health (1998) 1.11
Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study. Cancer (2014) 1.05
Axillary and supraclavicular recurrences are rare after axillary lymph node dissection in breast cancer. World J Surg (2012) 1.00
Multiple primary malignant neoplasms in England and Wales, 1971-1981. Yale J Biol Med (1987) 0.99
Cancer risks in thyroid cancer patients. Br J Cancer (1991) 0.96
Multiple primary tumours: incidence estimation in the presence of competing risks. Popul Health Metr (2009) 0.87
Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment. Br J Cancer (2003) 0.87
Non melanoma skin cancer and subsequent cancer risk. PLoS One (2014) 0.85
Multiple primary cancers in Denmark 1943-80; influence of possible underreporting and suggested risk factors. Yale J Biol Med (1987) 0.85
The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis. Cancer Epidemiol Biomarkers Prev (2016) 0.84
Prior history of non-melanoma skin cancer is associated with increased mortality in patients with chronic lymphocytic leukemia. Haematologica (2009) 0.82
Methodologic perspectives on the study of multiple primary cancers. Yale J Biol Med (1987) 0.82
Excess mortality from breast cancer 20 years after diagnosis when life expectancy is normal. Br J Cancer (2001) 0.81
Metachronous double primary cancer after treatment of breast cancer. Cancer Res Treat (2014) 0.81
Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study. PLoS One (2015) 0.81
Genetic implications of double primary cancers of the colorectum and endometrium. J Med Genet (1998) 0.79
Risk of new primary cancer in patients with oropharyngeal cancer. Br J Cancer (1994) 0.78
Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma. Br J Cancer (2014) 0.76
Increased incidence of cancer in first degree relatives of women with double primary carcinomas of the breast and colon. J Med Genet (1996) 0.76
Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution. World J Urol (2016) 0.75
A case of multiple synchronous quadruple cancers of the stomach, sigmoid colon, rectum, and pancreas. Int J Surg Case Rep (2017) 0.75
Risk of second primary malignancies among patients with prostate cancer: A population-based cohort study. PLoS One (2017) 0.75
Synchronous Primary Endometrial Carcinoma and Metastatic Malignant Melanoma in Cervical Lymph Node. J Clin Diagn Res (2017) 0.75
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49
Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet (2001) 6.23
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol (1994) 4.89
Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A (2001) 3.31
Coeliac disease--associated disorders and survival. Gut (1994) 3.13
Aggressiveness of screen-detected breast cancers. Lancet (1995) 3.07
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol (1982) 2.83
Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet (1994) 2.83
Survival of cancer patients in Finland 1955-1994. Acta Oncol (1999) 2.67
Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ (1997) 2.41
Social class as a prognostic factor in breast cancer survival. Cancer (1990) 2.37
Testicular cancer in nine northern European countries. Int J Cancer (1994) 2.32
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29
Risk of cancer in Finnish children living close to power lines. BMJ (1993) 2.29
Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology (2000) 2.25
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control (2000) 2.24
Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry (2001) 2.23
Cancer mortality among man-made vitreous fiber production workers. Epidemiology (1997) 2.10
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09
From cross-tabulations to multipurpose exposure information systems: a new job-exposure matrix. Am J Ind Med (1998) 2.07
Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut (2005) 2.07
Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med (1997) 2.06
Progression of asbestosis predicts lung cancer. Chest (1998) 2.02
Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl (2011) 1.96
Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland. J Natl Cancer Inst (1996) 1.93
Work-related cancer in the Nordic countries. Scand J Work Environ Health (1999) 1.84
Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect (1999) 1.84
Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol (1999) 1.84
Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol (1995) 1.84
Non-neoplastic mortality of European workers who produce man made vitreous fibres. Occup Environ Med (1999) 1.83
Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol (1999) 1.83
Incidence of childhood cancer in Finland. J Natl Cancer Inst (1975) 1.73
Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol (2000) 1.71
Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003. Sex Transm Infect (2007) 1.69
Sunlight as a risk factor of malignant melanoma of the skin. Cancer (1978) 1.65
Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut (2008) 1.64
Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med (1999) 1.63
Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet (2005) 1.61
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl (1986) 1.60
Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer (2000) 1.59
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer (2000) 1.58
Elevated lung cancer risk among persons with depressed mood. Am J Epidemiol (1996) 1.58
Cancer incidence among 78,000 asthmatic patients. Int J Epidemiol (1993) 1.58
Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Environ Med (1995) 1.56
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer (1999) 1.56
Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol (1997) 1.56
Magnetic fields of high voltage power lines and risk of cancer in Finnish adults: nationwide cohort study. BMJ (1996) 1.55
Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ (1997) 1.55
Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst (2000) 1.54
Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res (2003) 1.54
Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer (1995) 1.52
Cancer in the offspring of fathers in hydrocarbon-related occupations. Br J Prev Soc Med (1976) 1.51
Selective screening: theory and practice based on high-risk groups of cervical cancer. J Epidemiol Community Health (1979) 1.48
Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol (2001) 1.46
Implementation of screening as a public health policy: issues in design and evaluation. J Med Screen (1999) 1.45
Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol (1988) 1.45
Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients. Br J Dermatol (2012) 1.40
Stability over time of serum antibody levels to human papillomavirus type 16. J Infect Dis (1998) 1.39
Incidence and mortality from breast cancer in the Mama Program for Breast Screening in Finland, 1973-1986. Cancer (1994) 1.38
A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prev (1994) 1.36
Reliability of histopathologic diagnosis of malignant lymphoma. Ann Clin Res (1973) 1.35
Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis (2006) 1.35
Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas. Cancer (1983) 1.33
Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst (1990) 1.33
Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol (1993) 1.32
Dietary antioxidants and the risk of lung cancer. Am J Epidemiol (1991) 1.32
Spatial temporal patterns in childhood leukaemia: further evidence for an infectious origin. EUROCLUS project. Br J Cancer (1998) 1.31
Breast cancer risk among Finnish cabin attendants: a nested case-control study. Occup Environ Med (2005) 1.27
Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer (2009) 1.26
Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland. Br J Cancer (2007) 1.25
Cancer incidence in a kidney-transplanted population. Transpl Int (2000) 1.25
Social class and cancer patient survival in Finland. Am J Epidemiol (1995) 1.24
A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis (2001) 1.22
Education, survival and avoidable deaths in cancer patients in Finland. Br J Cancer (2010) 1.21
Leanness and lung-cancer risk. Int J Cancer (1991) 1.21
The Helsinki Heart Study: an 8.5-year safety and mortality follow-up. J Intern Med (1994) 1.20
Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis (1992) 1.20
Dietary fat and risk of breast cancer. Am J Clin Nutr (1990) 1.20
Genetic predisposition, environment and cancer incidence: a nationwide twin study in Finland, 1976-1995. Int J Cancer (1999) 1.20
Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer (2002) 1.20
The Estonian study of Chernobyl cleanup workers: II. Incidence of cancer and mortality. Radiat Res (1997) 1.20
Selective screening for cervical cancer. Experience of the Finnish mass screening system. Br J Prev Soc Med (1977) 1.18
Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol (1996) 1.18
Drinking water mutagenicity and gastrointestinal and urinary tract cancers: an ecological study in Finland. Am J Public Health (1994) 1.18
Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control (1997) 1.18
Cancer risk after metal on metal and polyethylene on metal total hip arthroplasty. Clin Orthop Relat Res (1996) 1.16
A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease. Clin Cancer Res (2000) 1.16